Form D · Other Technology
Juvena Therapeutics, Inc.
Redwood City, CA · CIK 0001732720
Offering snapshot reported Jul 25, 2025 · SEC filing
- Reported sold
- $30.5M Offering amount: $41M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2025 | Initial | $30,493,884 | No comparison | 12 | SEC filing |
| Feb 26, 2018 | Initial | $4,314,989 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552759
Source: Form D, filed Jul 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ayman Al Abdallah | Director |
| Ben Hemani | Director |
| Steven James | Director |
| Stephen Juelsgaard | Director |
| Christopher Kirk | Director |
| Laura Lande Diner | Director |
| Jeremy O'connell | Director |
| Hanadie Yousef | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
640 Galveston Drive
Redwood City, CA, 94063
Redwood City, CA, 94063